FDA grants accelerated approval to belantamab mafodotin-blmf for multiple myelomaNov 6Regulatory decisionbelantamabbelantamab mafodotin
FDA approves subcutaneous Sarclisa Escena with on-body injector for multiple myelomaJul 15Regulatory decisionisatuximabisatuximab-irfc
FDA approves Sarclisa Escena, a new dosage form from SanofiJul 9Regulatory decisionisatuximabisatuximab-irfc